Koers Zhejiang Cheng Yi Pharmaceutical Co., Ltd.
Aandelen
603811
CNE100002YC7
Farmaceutische producten
slotkoers
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
8,3 CNY | +1,10% | +10,37% | -19,96% |
Omzet 2022 | 655 mln. 90,47 mln. 84,36 mln. | Omzet 2023 | 672 mln. 92,77 mln. 86,51 mln. | Marktkapitalisatie | 3,39 mld. 469 mln. 437 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2022 | 162 mln. 22,38 mln. 20,87 mln. | Nettowinst (verlies) 2023 | 163 mln. 22,52 mln. 21 mln. | EV/omzet 2022 | 5,32 x |
Nettoschuld 2022 | 213 mln. 29,46 mln. 27,47 mln. | Nettoschuld 2023 | 150 mln. 20,68 mln. 19,28 mln. | EV/omzet 2023 | 5,28 x |
K/w-verhouding 2022 |
20,3
x | K/w-verhouding 2023 |
20,7
x | Werknemers | 746 |
Dividendrendement 2022 |
1,79% | Dividendrendement 2023 |
-
| Vrij verhandelbaar | 61,24% |
1 dag | +1,10% | ||
1 week | +10,37% | ||
Lopende maand | +4,67% | ||
1 maand | +4,67% | ||
3 maanden | +0,85% | ||
6 maanden | -20,42% | ||
Lopend jaar | -19,96% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Chun Jian Zhao
CEO | Chief Executive Officer | 47 | 23-04-18 |
Sun Zhan Lü
DFI | Director of Finance/CFO | 45 | 12-03-16 |
Shi Sheng Li
BRD | Director/Board Member | 73 | 12-03-16 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Tao Jin
BRD | Director/Board Member | 56 | 06-05-19 |
Yi Yi Yan
CHM | Chairman | 75 | 12-03-16 |
Bing Jun Ren
BRD | Director/Board Member | 58 | 12-03-16 |
Datum | Koers | Variatie | Volume |
---|---|---|---|
30-04-24 | 8,3 | +1,10% | 4 691 196 |
29-04-24 | 8,21 | +3,14% | 4 077 819 |
26-04-24 | 7,96 | -1,00% | 4 945 398 |
25-04-24 | 8,04 | +1,26% | 3 730 540 |
24-04-24 | 7,94 | +2,45% | 2 891 468 |
slotkoers Shanghai S.E., 30 april 2024
Meer koersenVaira. 1 jan. | Kapi. | |
---|---|---|
-19,96% | 375 mln. | |
+29,68% | 699 mld. | |
+25,07% | 571 mld. | |
-4,35% | 364 mld. | |
+17,65% | 326 mld. | |
+3,77% | 286 mld. | |
+14,68% | 236 mld. | |
+4,71% | 198 mld. | |
-12,43% | 194 mld. | |
-3,79% | 154 mld. |